Premium
P1‐442: High‐dose donepezil extended‐release tablets provide additional benefit in patients with more advanced Alzheimer's who have already been treated with donepezil 10 mg once daily
Author(s) -
Yardley J.,
Moline M.,
Wang Q.,
Zou H.,
Brand-Schieber E.,
Hsu T.,
Satlin A.
Publication year - 2010
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2010.05.997
Subject(s) - donepezil , randomization , pharmacokinetics , population , concomitant , pharmacology , medicine , psychology , gastroenterology , randomized controlled trial , disease , dementia , environmental health